Skip to content Skip to footer
Google Buys Its Own Sunshine: Inside the $4.75 Billion Intersect Power Deal -( $GOOG $GOOGL )
Alphabet’s decision to acquire Intersect Power for roughly $4.75 billion is less a vanity green purchase…
From Benicia to the Bahamas: The Surprising Supply Chain Behind California’s Gas Spike -( $PSX $VLO )
California drivers are discovering that “California premium” at the pump comes with a 40‑cent surprise this…
Meta’s $10 Billion Indiana Data Bet: When AI Meets the Corn Belt -( $META )
Meta’s decision to plant a more-than-1-gigawatt data center in Lebanon, Indiana, reads like a statement that…
Gene Editing’s Next Act: How A Nobel Laureate Wants To Turn CRISPR From Hype To Habit
In an era when artificial intelligence has stolen most of biotech’s buzz, gene editing is quietly…
Gilead’s $7.8 Billion Bet on Arcellx: When CAR‑T Goes Prime Time for Multiple Myeloma -( $ACLX $GLD $XBI $IBB )
Gilead Sciences (GLD) is paying up to $7.8 billion to acquire Arcellx (ACLX) , a…
Varda Space Aims to Turn Low Earth Orbit into Pharma’s New Production Line
The new space economy is quietly adding an unexpected aisle to the drugstore: a “made‑in‑orbit” shelf…
Healthcare’s Favorite Scrub Maker Is Quietly Stitching a Bigger Future for FIGS
FIGS, Inc. (NYSE: FIGS) has built a rare position in retail: a founder-led, direct-to-consumer brand that…
Carvana’s Earnings Hit a Speed Bump: Record Sales, Market Throws On the Parking Brake -( $CVNA $SPY )
Carvana’s (CVNA) latest earnings report delivered record sales and solid profits, but Wall Street still sent…
The Big Mac Meets the Skinny Pill: How McDonald’s and Eli Lilly Are Sharing the Same Consumer -( $LLY $MCD )
McDonald’s (MCD) has handled low-carb fads, kale revolutions, and the brief reign of cauliflower rice, but…
Earnings, Algorithms, PCE and Iran: What Could Possibly Go Wrong? -( $DIA $QQQ $SPY $VIX )
Wall Street closed Thursday walking a now-familiar tightrope: cheering resilient earnings and AI-fueled innovation while eyeing…
How 2026 Turns Savers Into Shoppers in the New Banking Economy For Gen Z & Beyond
The coming year in banking looks surprisingly upbeat for savers who are willing to click, compare,…
Steve Ballmer’s Intuit Dome Unveiled: $2 Billion HQ Redefines Sports Arenas and Corporate Campuses -( $INTU $MSFT $SPY )
Intuit’s (INTU) latest splash isn’t in fintech, but in construction—where the budget now garners more buzz…
Varda Space Aims to Turn Low Earth Orbit into Pharma’s New Production Line
The new space economy is quietly adding an unexpected aisle to the drugstore: a “made‑in‑orbit” shelf…
Eupraxia’s Latest Raise: A Diffusphere-Fueled War Chest Aims at GI Disease -( $EPRX $IBB $XBI $SNY)
In a market that has grown wary of “story stocks,” Eupraxia Pharmaceuticals (NASDAQ: EPRX) just delivered…
Healthcare’s Favorite Scrub Maker Is Quietly Stitching a Bigger Future for FIGS
FIGS, Inc. (NYSE: FIGS) has built a rare position in retail: a founder-led, direct-to-consumer brand that…
Critical Minerals, Critical Money: How Japan and M2i–Volato Aim to Cash In on a $320 Billion Market -( $MTWO $SOAR )
Japan is about to become one of America’s biggest energy backers, wiring in a $36 billion…
Corning and Meta’s $6 Billion Fiber Tie-Up: AI’s New Glass Half Full -( $AMZN $GLW $META $NVDA $GOOG $MSFT )
Corning (GLW) and Meta (META) just inked a multiyear, up to $6 billion agreement that effectively…
Gold’s Best Week in Years and Silver’s Dash Toward $100: Is This the Start of a New Metals Supercycle? -( $GLD $SLV )
Gold just logged its best week since 2020 while silver flirted with triple digits, turning the…
Varda Space Aims to Turn Low Earth Orbit into Pharma’s New Production Line
The new space economy is quietly adding an unexpected aisle to the drugstore: a “made‑in‑orbit” shelf…
February 20, 2026- Tariffs, Tantrums, and a 1.1% Gain: Wall Street’s Surprisingly Chill Week -( $EPRX $NOK $NVDA $OPEN Rise!)
US stocks finished the holiday‑shortened week ended Friday, February 20, 2026 higher, as a landmark Supreme…
Gene Editing’s Next Act: How A Nobel Laureate Wants To Turn CRISPR From Hype To Habit
In an era when artificial intelligence has stolen most of biotech’s buzz, gene editing is quietly…
Gilead’s $7.8 Billion Bet on Arcellx: When CAR‑T Goes Prime Time for Multiple Myeloma -( $ACLX $GLD $XBI $IBB )
Gilead Sciences (GLD) is paying up to $7.8 billion to acquire Arcellx (ACLX) , a…
Google Buys Its Own Sunshine: Inside the $4.75 Billion Intersect Power Deal -( $GOOG $GOOGL )
Alphabet’s decision to acquire Intersect Power for roughly $4.75 billion is less a vanity green purchase…
Varda Space Aims to Turn Low Earth Orbit into Pharma’s New Production Line
The new space economy is quietly adding an unexpected aisle to the drugstore: a “made‑in‑orbit” shelf…
Eupraxia’s Latest Raise: A Diffusphere-Fueled War Chest Aims at GI Disease -( $EPRX $IBB $XBI $SNY)
In a market that has grown wary of “story stocks,” Eupraxia Pharmaceuticals (NASDAQ: EPRX) just delivered…
Amazon’s Amazing Theatrical Expansion – $AMZN $SPY
Amazon has unveiled ambitious plans to significantly increase its theatrical movie releases starting in 2025, aiming…
Lawrence Summers Warns of Economic Storm Clouds Ahead – $SPY $QQQ $DIA $VIX
Former Treasury Secretary Lawrence Summers has delivered a sobering outlook for the U.S. economy, suggesting that…
Your Guide To Staying Informed In The Markets

Subscribe For Free Email Updates Access To Exclusive Research

Vista Partners — © 2026 — Vista Partners LLC (“Vista”) is a Registered Investment Advisor in the State of California. Vista is not licensed as a broker, broker-dealer, market maker, investment banker, or underwriter in any jurisdiction. By viewing this website and all of its pages, you agree to our terms. Read the full disclaimer here